Home600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Previous close
¥2.82
Day range
¥2.80 - ¥2.85
Year range
¥2.41 - ¥3.90
Market cap
7.11B CNY
Avg Volume
29.90M
P/E ratio
17.69
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.88B | 1.53% |
Operating expense | 890.39M | 3.71% |
Net income | 106.28M | -65.58% |
Net profit margin | 2.74 | -66.13% |
Earnings per share | — | — |
EBITDA | 232.38M | -18.97% |
Effective tax rate | 26.56% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.06B | 25.76% |
Total assets | 14.11B | 5.04% |
Total liabilities | 8.69B | 2.37% |
Total equity | 5.42B | — |
Shares outstanding | 2.52B | — |
Price to book | 1.51 | — |
Return on assets | 3.01% | — |
Return on capital | 5.83% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 106.28M | -65.58% |
Cash from operations | 209.10M | -56.28% |
Cash from investing | -91.56M | -235.94% |
Cash from financing | 91.46M | 205.63% |
Net change in cash | 208.09M | -63.79% |
Free cash flow | 146.69M | -80.26% |
About
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Founded
1988
Website
Employees
9,853